NeoGenomics shares rose 6.5% to $10.19 on May 28, 2026, placing the stock near the upper end of its 52-week range of $4.72 to $13.74. The move appears to be a price action update rather than a fundamental catalyst, but it signals positive near-term momentum in the name.
NeoGenomics shares rose 6.5% to $10.19 on May 28, 2026, placing the stock near the upper end of its 52-week range of $4.72 to $13.74. The move appears to be a price action update rather than a fundamental catalyst, but it signals positive near-term momentum in the name.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
